With the Nasdaq at record highs, these are the benchmark’s most beloved stocks that are expected to rally
The tech-heavy index closed at its first record high in more than two years on Thursday. Source link
Read More
Biogen Inc
What Eli Lilly investors can learn from the slow launch of a competitor’s drug
The rollout of Alzheimer's treatment Leqembi from Biogen is going slower than expected, providing a read-through for Club stock Eli
Read More
Stocks making the biggest moves midday: JetBlue Airways, Shopify, Biogen and more
These are the stocks posting the largest moves in midday trading. Source link
Read More
The S&P 500 will try to maintain its momentum next week after breaching 5,000, with key inflation data, earnings on deck
The 5,000 milestone is psychologically significant for investors, who are weighing whether stocks have further upside from here. Source link
Read More
Will the ‘Magnificent Seven’ have another good run in 2024? Morgan Stanley’s Mike Wilson weighs in
The investment bank's chief U.S. equity strategist says the risk of recession will be higher than normal next year —
Read More
More convenient form of breakthrough Alzheimer’s drug Leqembi shows promising results in study
Eisai and Biogen said in a release that they plan to apply for U.S. approval of subcutaneous Leqembi by the
Read More
This defense contractor and automaker are among the most oversold S&P 500 stocks
Take a look at some of the most oversold and overbought stocks in the S&P 500 this week. Source link
Read More
Wall Street rides high into next week as traders brace for a major Fed decision and key earnings
The Dow Jones Industrial Average is set to close out a 10-day winning streak on Friday. Source link
Read More
Medicare will pay for Alzheimer’s drug Leqembi. What patients and doctors should know
Patients with early Alzheimer's disease could still pay more than $5,000 in out-of-pocket costs for Leqembi even with Medicare coverage.
Read More